# An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

> **NCT00428701** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 40 (estimated)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** Esomeprazole Sodium

## Key facts

- **NCT ID:** NCT00428701
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428701, "An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00428701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*